~," Atrial natriuretic factor (ANF) is a diuretic natriuretic peptide hormone produced by both the heart and brain which has been postulated to play a role in the hemodynamic and sodium instability that frequently follows subarachnoid hemorrhage (SAH). Levels of ANF were measured in 12 patients with nontraumatic SAH and nine control patients with unruptured cerebral aneurysms. At surgery, the mean plasma ANF level (_+ standard deviation) of the SAH group was significantly higher than that of the control group (158.1 -+ 83.8 vs. 57.8 + 45.3 pg/ml, respectively; p = 0.01). There was no significant difference in serum sodium concentration, blood pressure, or central venous pressure between these groups. Nine patients with SAH due to aneurysm rupture had plasma ANF levels similar to those in three patients with SAH due to other causes. Four patients with moderate to severe SAH had significantly higher mean cerebrospinal fluid (CSF) ANF values (17.7 _+ 12.8 pg/ml) than five patients with minimal SAH (0.6 _+ 0.9 pg/ml) or the control group of nine patients (3.7 + 1.3 pg/ml) (p < 0.05). Five patients with moderate to severe SAH had significantly higher plasma ANF values (202.6 _+ 72.2 pg/ml) than five with minimal SAH (86.8 + 29.2 pg/ml) or the control group (57.8 _+ 45.3 pg/ml) (p < 0.05). Plasma ANF values were substantially higher than CSF ANF content in the SAH group (p < 0.01) and in the control group (p = 0.05).
TRIAL natriuretic factor (ANF) is a potent diuretic natriuretic hormone which is important in the control of blood pressure and sodium hemostasis5 This hormone is produced by the atrial myocardial cells ~'8 and by the mammalian brain, which has receptors for ANF. ~~ Electrolyte disturbances, particularly hyponatremia,~3 hemodynamic instability, and hypovolemia, 9 are common after subaracbnoid hemorrhage (SAH). Hyponatremia after SAH has been commonly attributed to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) 4~6 and to a lesser extent to cerebral salt-wasting. 9 Atrial natriuretic factor could cause or contribute to cerebral salt-wasting, which may result in hyponatremia or hypovolemia. The present study examines whether ANF is increased after SAH and attempts to localize the source of this increase by measuring ANF in blood and cerebrospinal fluid (CSF) concurrently.
Clinical Material and Methods

Patient Population
Twenty-one adults with either SAH or unruptured cerebral aneurysms who were admitted to the Neurosurgery Intensive Care Unit of the Cleveland Clinic Foundation between August, 1987, and March 1988, were studied (Table 1 ). The study group comprised 12 patients with SAH. Of these, seven were women and five were men, with a mean age of 44.2 years (range 26 to 63 years). Nine of the 12 study group patients had aneurysms, one had a tentorial dural arteriovenous malformation (AVM), and two had intracerebral and intraventricular hemorrhage with secondary SAH. All but two patients (Cases 10 and 11) underwent craniotomy and obliteration of the bleeding source by aneurysm clipping or excision of an AVM. There were nine patients with unruptured aneurysms in the control group. The group included six women and three men, with a mean age of 51.6 years (range 35 to 59 years). All nine patients in the control group underwent elective craniotomy and clipping of the aneurysms.
All patients were studied with angiography. The diagnosis of SAH was confirmed by direct observation at operation, computerized tomography evidence of subarachnoid blood, or xanthochromic CSF after centrifugation.
General anesthesia was induced using sodium thiopental and was maintained with nitrous oxide, isoflurane, and fentanyl or sufentanyl. Pancuronium bromide was used for muscle paralysis. Blood pressure was monitored continuously, and normotension was achieved by titrated administration of sodium nitroprusside or isoflurane. Surgery was performed using standard craniotomy approaches and microsurgical techniques.
Atrial Natriuretic Factor
Each patient was maintained in a supine position for a minimum of 20 minutes prior to collection of blood to avoid postural effects on ANF concentration. Ten milliliters of venous blood was collected from the fight atrium by means of a central venous catheter and was immediately mixed with 1 ml of ethylenediaminetetraacetic acid and aprotinin. The specimen was chilled and then pre-extracted to avoid loss of significant amounts of ANF. The plasma was passed through a C 18 column of silica gel, and column chromatography was performed. The final specimen was stored in buffered phosphate at a pH at 7.4. A radioimmunoassay was then performed, using a specific antibody and iodinated ANF tracer.
Specimens of CNS ANF and venous ANF were collected concurrently, and systolic blood pressure, diastolic blood pressure, central venous pressure, and serum sodium were measured at this time. Approximately 5.0 cc of CSF was aspirated from the basal cisterns during initial exposure of the aneurysm. In the two patients who did not undergo surgery (Cases 10 and 11), CSF was collected from the lateral ventricles via a ventricular catheter. The CSF and venous samples were processed identically for ANF assay. Because of the diurnal variation in ANF secretion (maximal in the t Significance of difference between the two groups was determined by unpaired t-test.
evening, peaking at 4:00 a.m., with a nadir in midafiernoon), 6 all ANF samples were collected at approximately 10:00 a.m.
Statistical Analysis
Comparisons of venous ANF, CSF ANF, serum sodium, systolic blood pressure, diastolic blood pressure, and central venous pressure between the study and * Findings are based on evidence from computerized tomography scanning or lumbar puncture. ANF = atrial natriuretic factor; SAH = subarachnoid hemorrhage; SD = standard deviation. Significance of difference between the mild-SAH group (graded + or ++ in Table 1 ) and the moderate-to severe-SAH group (graded +++ or ++++ in Table 1 ) was calculated by the unpaired t-test (p = 0,01 ).
control groups were performed using the unpaired Student t-test. ~2 The nonparametric Wilcoxon rank-sum test 12 and chi-square tests were used to confirm comparisons between the CSF ANF of the experimental and control groups. The difference between the venous ANF and CSF ANF in individual patients was determined using the paired Student t-test. A comparison of venous ANF between patients with mild SAH and those with moderate to severe SAH was performed using the unpaired Student t-test. Pearson's correlation was used to analyze the relationship of venous ANF and central venous pressure. ~2 Due to missing observations, analyses for different variables and groups have different numbers of individuals.
Results
The diagnosis, timing of surgery, and degree of SAH in the 21 patients in the series are presented in Table 1 . The normal range of serum ANF in our laboratory (_+ standard deviation) is 29.8 _+ 3.0 pg/ml for control subjects on a normal sodium diet and 46.2 + 9.1 pg/ ml for hypertensive patients. Table 2 gives the ANF concentration in plasma and CSF and the corresponding serum sodium, systolic blood pressure, diastolic blood pressure, and central venous pressure in the present series. At surgery, mean venous ANF in the study group was significantly higher than in the control group (158.1 _+ 83.8 pg/ml vs. 57.8 _+ 45.3 pg/ml, respectively; p = 0.01) (Fig. 1 and Table 2 ) and on average peaked on Day 9 after SAH. Although no difference was found between mean CSF ANF levels in the study and control groups (9.2 pg/ml and 3.7 pg/ml, respectively; p > 0.10) ( Table 2) , patients with severe SAH had higher venous ANF levels (Table 3) and CSF ANF levels (Table 4) (p < 0.05) than those with mild SAH or the control group. Within the study group, the mean plasma ANF level in the nine patients with aneurysm rupture was no different from the mean level in those with other causes of SAH (142.8 + 79.9 pg/ml vs. 135.3 _+ 52.5 pg/ml). In comparing the study and control groups, there was no statistical difference (p > 0.10) in the mean serum Table 1 ). ]-he difference between the extensive-SAH group and the other two groups was significant at p < 0.05 (chi-square test). CSF = cerebrospinal fluid: A N F = atrial natriuretic factor. Table 2) .
The blood ANF level was higher than the CSF ANF concentration in both the study group (p < 0.01) and the control group (p = 0.05) ( Table 5) . The relationship between central venous pressure and venous ANF levels was significant in the control group (r = 0.08, p < 0.01) but not in the study group.
Discussion
The control and study group patients in this series are well matched, differing only in whether SAH had occurred ( Table 1 ). The results indicate that plasma ANF content is significantly elevated in patients after SAH compared with the control group with unruptured aneurysms, and that the CSF ANF level is substantially lower. The rise in serum ANF and CSF ANF levels appears to be related to the presence and amount of subarachnoid blood and does not relate to the serum sodium concentration, systolic blood pressure, diastolic blood pressure, or central venous pressure, or to the cause of SAH ( Table 2 ). The lack of correlation between plasma ANF level and central venous pressure in the SAH group also indicates that ANF is not released solely in response to increased fight atrial pressure after SAH as is the case in the control group (Fig. 2) . ~~
Mechanism of ANF Secretion
Both the heart and the brain are potential sources of the changes in ANF levels after SAH. Receptors for ANF are present in many parts of the mammalian brain, and ANF is present in rat hypothalamus, the organ vasculosum of the lamina terminalis, and the dorsolateral tegmentum of the pons."l l
The results of our investigation show that the release of ANF, both systemically and in the CSF, is related to the presence and amount of subarachnoid blood in the basal cisterns, but not to the cause of the hemorrhage. Diringer, et al., 3 found peak ANF levels on Day 3 after SAH, while in our study peak levels occurred on Day 9 and were somewhat higher. These findings would suggest that, although initial elevations of ANF may be due to the direct spillage of ANF-laden blood in the CSF at the time of SAH or to release from disrupted brain, peak levels are related to some delayed or indirect consequence of the hemorrhage.
The presence and amount of subarachnoid blood has also previously been linked to cerebral vasospasm 7 which, in turn, is linked to hyponatremia. Hypothalamic ischemia and hemorrhagic damage occur in patients with hyponatremia after SAH? 3 Such ischemia as a result of vasospasm could explain either a direct release of ANF into the circulation or an indirect neural effect on the heart, causing increased ANF levels in blood. The results of this study may support the latter explanation for three reasons. 1) Cardiopulmonary complications commonly occur following SAH, and the lack of correlation between central venous pressure and ANF levels in the SAH group is consistent with altered cardiac physiology, w 2) Levels of ANF in CSF were very low compared to plasma levels, suggesting that the brain was not the source of the elevated plasma ANF.
3) The rise in CSF ANF levels was nearly proportionate to the increases seen in the blood values as compared to the control group. This suggests that the source of most of the CSF ANF was the blood.
An exact determination of the source of blood ANF requires measuring arteriovenous differences within the brain and venous-arterial differences within the heart. Such an investigation is being conducted by our unit and will be the subject of a future report.
Elevated blood ANF levels may be only indirectly related to the presence of subarachnoid blood and could be a relatively nonspecific marker of raised intracranial pressure (ICP), which produces injury to the hypothalamus or to other ANF-containing or ANF-regulating structures. Intracranial hypertension is often associated with severe SAH. D6czi, et al., 5 found elevated ANF values in patients with raised ICP after SAH. In three patients in our unit with no evidence of SAH and high ICP (two with subdural hematomas and one with hemispheric infarction), mean blood ANF levels were substantially elevated (197.7 + 52.1 pg/ml). Since ANF has been implicated as a central regulator of brain sodium and water balance, 5 its release as a response to raised ICP may be adaptive, although potentially undesirable, in the setting of cerebral ischemia due to vasospasm.
ANF, Sodium Balance, and SAH
Hyponatremia is common after SAH; it occurs most often after anterior communicating artery aneurysm rupture and is associated with a poor prognosis. ~3 The reported incidence of hyponatremia varies from 7.1% in operated cases and 15% in unoperated cases 13 to 33%. 15 It has been directly associated with clinical deterioration including focal neurological signs. 8 Traditionally, hyponatremia after SAH has been attributed to SIADH; 4'16 however, Nelson, eta[., 9 demonstrated low blood volume in 10 of 12 patients who met laboratory criteria for SIADH. They postulated the cause of hyponatremia in this setting to be the cerebral salt-wasting syndrome. A negative sodium balance precedes hyponatremia and lowered blood volume following SAH. ~5 The secretion of a natriuretic factor such as ANF could account for these changes.
The relationship of increased blood and CSF ANF levels to sodium and water regulation after SAH remains unclear. Serum sodium concentrations were slightly lower in the SAH group, which is what would be expected with higher ANF concentrations causing a natriuresis. The lack of a substantial decrease in serum sodium levels may be due to aggressive fluid and electrolyte replacement. However, Diringer, et al., -~ failed to find elevated plasma ANF levels in two SAH patients with hyponatremia as compared to 19 normonatremic SAH patients. It may be that ANF has only a limited role, if any, in the changes in blood sodium levels after SAH. A recently described natriuretic digoxin-like substance found after SAH may prove to be a more important factor. ~4 Investigations of sodium and water balances presently under way in our unit may help resolve this issue.
An ANF antiserum has been used experimentally to suppress the effects of ANF natriuretic in rats.' If ANF is shown to be a major factor in the pathogenesis of cerebral salt-wasting, an ANF antagonist may prevent the unwanted sequelae of this condition in patients with SAH.
